Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • Heart Failure
    #Redirect [[Heart failure]]
    27 bytes (3 words) - 23:44, 29 April 2008
  • Chf
    #redirect [[Heart failure]]
    27 bytes (3 words) - 08:22, 8 November 2007
  • Diastolic dysfunction
    #REDIRECT [[Diastolic heart failure]]
    37 bytes (4 words) - 11:44, 1 March 2010
  • Lisinopril/Definition
    ...itor class that is primarily used in treatment of hypertension, congestive heart failure, heart attacks and also in preventing renal and retinal complications of di
    262 bytes (36 words) - 06:37, 4 January 2010
  • Nesiritide/Definition
    A synthetic [[brain natriuretic peptide]] used for the treatment of [[heart failure]]
    121 bytes (15 words) - 20:41, 2 March 2010
  • Diastolic heart failure/Definition
    [[Heart failure]] caused by abnormal myocardial relaxation during diastolic leading to defe
    183 bytes (20 words) - 18:05, 14 May 2010
  • Angiotensin-converting enzyme inhibitor/Definition
    Drugs mainly used to treat [[hypertension]] and [[heart failure]], by hemodynamic effect inhibiting the [[renin-angiotensin system]].
    169 bytes (19 words) - 09:11, 19 September 2009
  • Framingham congestive-heart-failure score/Definition
    Score that can be used to diagnose heart failure and monitor its response to treatment.
    123 bytes (18 words) - 16:17, 18 November 2011
  • Dilated cardiomyopathy/Definition
    ...racterized by [[ventricular dilation]], [[ventricular dysfunction]], and [[heart failure]].
    146 bytes (17 words) - 12:04, 2 July 2009
  • Framingham congestive-heart-failure score
    ...l| author=Ho KK, Pinsky JL, Kannel WB, Levy D| title=The epidemiology of heart failure: the Framingham Study. | journal=J Am Coll Cardiol | year= 1993 | volume= ...l| author=Ho KK, Pinsky JL, Kannel WB, Levy D| title=The epidemiology of heart failure: the Framingham Study. | journal=J Am Coll Cardiol | year= 1993 | volume=
    3 KB (389 words) - 10:15, 17 October 2010
  • New York Heart Association Functional Classification/Definition
    Way of classifying the extent of heart failure, by placing patients in one of four categories based on how much they are l
    191 bytes (29 words) - 04:45, 8 September 2009
  • Cardiotonic agent
    ...; cardiac surgical procedures; in shock; or in congestive heart failure ([[heart failure]])."<ref>{{MeSH}}</ref>
    989 bytes (121 words) - 11:27, 12 June 2010
  • Circulatory system/Related Articles
    {{r|Heart failure}}
    438 bytes (59 words) - 15:41, 16 February 2009
  • Natriuretic peptide
    ...mi AM, Moe G, Januzzi JL, Mazer CD| title=Improving the diagnosis of acute heart failure using a validated prediction model. | journal=J Am Coll Cardiol | year= 200 ...ystematic review and individual patient data meta-analysis of diagnosis of heart failure, with modelling of implications of different diagnostic strategies in prima
    3 KB (397 words) - 13:33, 15 June 2012
  • Dronedarone
    ...and [[New York Heart Association Functional Classification]] class I-III [[heart failure]] according to the ATHENA [[randomized controlled trial]].<ref name="pmid19 ...ANDROMEDA study because they had been "hospitalized with new or worsening heart failure and who had had at least one episode of shortness of breath on minimal exe
    2 KB (288 words) - 22:25, 7 July 2011
  • New York Heart Association Functional Classification/Related Articles
    {{r|Heart failure}}
    565 bytes (72 words) - 18:59, 11 January 2010
  • Nesiritide/Related Articles
    {{r|Heart failure}} -->
    281 bytes (37 words) - 20:45, 2 March 2010
  • Lisinopril
    .../ref> is an oral long-acting medication primarily used to treat congestive heart failure and high blood pressure ([[hypertension]]), and to improve survival after h ...aking lisinopril: kidney disease, liver disease, heart disease, congestive heart failure, diabetes, or connective tissue disease.
    2 KB (284 words) - 04:33, 14 February 2010
  • Tolvaptan
    ...of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. | journal=JAMA | year= 2007 | volume= ...l.| title=Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. | journal=JAMA | year= 2007 | volume= 297 | iss
    2 KB (342 words) - 10:20, 17 October 2010
  • Framingham Heart Study
    2 KB (337 words) - 23:20, 7 July 2011
  • Nesiritide
    ...itide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med. 2000 Jul 27;343(4):246-53. Erratum i Nesiritide is considered adjunctive therapy for patients in severe heart failure, principally as a vasodilator, when neither [[nitroglycerine]] nor [[sodium
    2 KB (299 words) - 21:01, 2 March 2010
  • New York Heart Association Functional Classification
    2 KB (272 words) - 13:05, 7 February 2023
  • Angiotensin-converting enzyme inhibitor
    ...f drugs whose main indications are the treatment of [[hypertension]] and [[heart failure]]. They exert their hemodynamic effect mainly by inhibiting the [[renin-ang ===Heart failure===
    5 KB (688 words) - 21:20, 2 September 2011
  • Eplerenone
    ...954024 Review in: ACP J Club. 2003 Sep-Oct;139(2):32] </ref> symptoms of [[heart failure]]. ...ith eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. | journal=Circ Heart Fail | year
    3 KB (447 words) - 13:22, 2 February 2023
  • Diastolic heart failure
    ...stolic heart failure''' or '''diastolic dysfunction''' is "[a subset of] [[heart failure]] caused by abnormal myocardial relaxation during diastolic leading to defe ...JE| title=Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. | journal=Ann Intern Med | year= 1992 | volume=
    8 KB (1,156 words) - 17:15, 18 December 2013
  • Phlebotomy/Related Articles
    {{r|Heart failure}}
    429 bytes (55 words) - 13:57, 26 February 2024
  • Hypertension/Related Articles
    {{r|Heart failure}}
    553 bytes (57 words) - 11:06, 29 July 2009
  • Selenium
    ...Z, Güllü H, Taşkapan H et al.| title=Trace element status (Se, Zn, Cu) in heart failure. | journal=Anadolu Kardiyol Derg | year= 2006 | volume= 6 | issue= 3 | page ...ity-of-life and left ventricular function in elderly patients with chronic heart failure. | journal=Eur Heart J | year= 2005 | volume= 26 | issue= 21 | pages= 2238-
    6 KB (795 words) - 23:14, 20 April 2011
  • Brain natriuretic peptide/Related Articles
    {{r|Heart failure}}
    469 bytes (60 words) - 11:29, 11 January 2010
  • Critical pathway/Related Articles
    {{r|Heart failure||**}}
    674 bytes (82 words) - 14:19, 9 April 2011
  • Implantable cardioverter defibrillator/Related Articles
    {{r|Heart failure}}
    499 bytes (63 words) - 17:24, 11 January 2010
  • Chlorthalidone/Related Articles
    {{r|Heart failure}}
    487 bytes (62 words) - 11:50, 11 January 2010
  • Troponin/Related Articles
    {{r|Heart failure}}
    518 bytes (67 words) - 21:06, 11 January 2010
  • Contrast-induced nephropathy/Related Articles
    {{r|Heart failure}}
    573 bytes (72 words) - 15:40, 11 January 2010
  • Central venous pressure/Related Articles
    {{r|Heart failure}}
    572 bytes (73 words) - 11:44, 11 January 2010
  • Echocardiography
    ==Heart failure== ...h can estimate the left ventricular ejection fraction in order to detect [[heart failure]].<ref name="pmid6627386">{{cite journal |author=Tortoledo FA, Fernandez GC
    4 KB (520 words) - 20:57, 29 August 2011
  • Eplerenone/Related Articles
    {{r|Heart failure}}
    584 bytes (74 words) - 16:21, 11 January 2010
  • Pharmacogenomics/Related Articles
    {{r|Heart failure}}
    608 bytes (78 words) - 19:29, 11 January 2010
  • Implantable cardioverter defibrillator
    ...tle=Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure |journal=N. Engl. J. Med. |volume=352 |issue=3 |pages=225–37 |year=2005 |
    2 KB (318 words) - 16:13, 15 February 2009
  • Spironolactone/Related Articles
    {{r|Heart failure}}
    645 bytes (84 words) - 20:33, 11 January 2010
  • Phosphodiesterase
    ..., ''et al'' |title=Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group |journal=N. Engl. J. Med. |volume=325 |is
    3 KB (433 words) - 06:47, 23 September 2011
  • Glomerular filtration rate/Related Articles
    {{r|Heart failure}}
    660 bytes (85 words) - 16:54, 11 January 2010
  • Aldosterone/Related Articles
    {{r|Heart failure}}
    758 bytes (96 words) - 10:47, 11 January 2010
  • G-protein-coupled receptor kinase/Related Articles
    {{r|Heart failure}}
    641 bytes (79 words) - 16:44, 11 January 2010
  • Thalassemia/Related Articles
    {{r|Heart failure}}
    790 bytes (106 words) - 20:53, 11 January 2010
  • Aldosterone antagonist
    ===Heart failure=== * [[Heart failure]]
    6 KB (789 words) - 00:07, 21 February 2011
  • Abdominojugular test
    ...name="pmid9169900">Review: Subtle clinical findings can detect left-sided heart failure in adults. ACP J Club. 1998 Jan-Feb;128(1):11. Review of [http://pubmed.go
    4 KB (525 words) - 07:42, 4 May 2024
  • Brain natriuretic peptide
    ...NP, [[nesiritide]] (trade name Natrecor), is also given as a treatment for heart failure. |+ Usig the BNP to detect heart failure<ref name="pmid12124404"/>
    11 KB (1,470 words) - 14:35, 18 March 2024
  • Clinical practice guideline/Related Articles
    {{r|Heart failure}}
    2 KB (310 words) - 12:22, 18 April 2024
  • Heart rate
    ...lysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure |journal=Ann. Intern. Med. |volume=150 |issue=11 |pages=784–94 |year=2009
    6 KB (877 words) - 07:39, 7 September 2011
View (previous 50 | ) (20 | 50 | 100 | 250 | 500)
Retrieved from "https://citizendium.org/wiki/Special:Search"